Litcius/Paper detail

CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys

Xiaojing Yang, Wu Luo, Li Li, Xiang Hu, Ming‐Jiang Xu, Yi Wang, Jianpeng Feng, Jianchang Qian, Xinfu Guan, Yunjie Zhao, Guang Liang

2021Toxicology and Applied Pharmacology14 citationsDOI

Topics & Concepts

Diabetic nephropathyInflammationDiabetes mellitusFibrosisCancer researchAP-1 transcription factorMAPK/ERK pathwayKidneyInternal medicineNephropathyEndocrinologyKinaseKidney diseaseBiologyMedicineCell biologyGene expressionBiochemistryGeneCancer-related Molecular PathwaysChronic Kidney Disease and DiabetesEpigenetics and DNA Methylation
CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys | Litcius